JEFFREY S MATHIESEN Insider Trading $NRBO NeuroBo Pharmaceuticals, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JEFFREY S MATHIESEN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JEFFREY S MATHIESEN. JEFFREY S MATHIESEN is Vice President and CFO in DELPHAX TECHNOLOGIES INC ($DLPX) and Director in NEUROONE MEDICAL TECHNOLOGIES Corp ($NMTC) and Director in Sun BioPharma, Inc. ($SNBP) and Chief Financial Officer in Gemphire Therapeutics Inc. ($GEMP).
JEFFREY S MATHIESEN in NeuroBo Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JEFFREY S MATHIESEN: Chief Financial Officer
Holdings: 14,134 shares
Current Value: $151,516
Latest Transaction: Jan 30 2018
$NRBO Market Capitalization: $97.34M
$NRBO Previous Close: $10.72
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JEFFREY S MATHIESEN in NeuroBo Pharmaceuticals, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, DLPX, NRBO, NMTC, SNBP
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 30 2018 | GEMP | Gemphire Therapeut ... | MATHIESEN JEFFREY S | Chief Financial Off ... | Option Exercise | A | 10.10 | 48,000 | 484,800 | 48,000 | |
| Aug 16 2017 | GEMP | Gemphire Therapeut ... | MATHIESEN JEFFREY S | Chief Financial Off ... | Option Exercise | M | 3.59 | 3,207 | 11,513 | 0 | |
| Aug 16 2017 | GEMP | Gemphire Therapeut ... | MATHIESEN JEFFREY S | Chief Financial Off ... | Buy | M | 3.59 | 3,207 | 11,513 | 14,134 | 10.9 K to 14.1 K (+29.35 %) |
| Aug 11 2017 | GEMP | Gemphire Therapeut ... | MATHIESEN JEFFREY S | Chief Financial Off ... | Option Exercise | M | 3.59 | 3,000 | 10,770 | 0 | |
| Aug 11 2017 | GEMP | Gemphire Therapeut ... | MATHIESEN JEFFREY S | Chief Financial Off ... | Buy | M | 3.59 | 3,000 | 10,770 | 10,927 | 7.9 K to 10.9 K (+37.85 %) |
| Aug 12 2016 | GEMP | Gemphire Therapeut ... | MATHIESEN JEFFREY S | Chief Financial Off ... | Buy | P | 10.00 | 4,000 | 40,000 | 7,927 | 3.9 K to 7.9 K (+101.86 %) |
| Aug 12 2016 | GEMP | Gemphire Therapeut ... | MATHIESEN JEFFREY S | Chief Financial Off ... | Buy | P | 10.00 | 4,000 | 40,000 | 7,927 | 3.9 K to 7.9 K (+101.86 %) |
| Aug 12 2016 | GEMP | Gemphire Therapeut ... | MATHIESEN JEFFREY S | Chief Financial Off ... | Buy | C | 6.71 | 3,927 | 26,334 | 3,927 | 0 to 3.9 K |
| Aug 12 2016 | GEMP | Gemphire Therapeut ... | MATHIESEN JEFFREY S | Chief Financial Off ... | Buy | C | 6.71 | 3,927 | 26,334 | 3,927 | 0 to 3.9 K |
| Aug 08 2016 | GEMP | Gemphire Therapeut ... | MATHIESEN JEFFREY S | Chief Financial Off ... | Option Exercise | A | 10.00 | 210,000 | 2,100,000 | 210,000 |
Page: 1